Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haus

Showing results (851-860 of 883) with videos related to

Pageof 89
Sort By:
Breast Cancer Research and Treatment|June 28, 2005
Breast cancer predisposing alleles in PolandB Górski, C Cybulski, T Huzarski, et al.
Journal of Medical Genetics|May 10, 2005
A common variant of CDKN2A (p16) predisposes to breast cancerT Debniak, B Górski, T Huzarski, et al.
Breast Cancer Research and Treatment|October 15, 2013
Preemptive tumor profiling for biomarker-stratified early clinical drug development in metastatic breast cancer patientsAnja Welt, Mitra Tewes, Bahriye Aktas, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 20, 2014
Submesoscale dispersion in the vicinity of the Deepwater Horizon spillAndrew C Poje, Tamay M Ozgökmen, Bruce L Lipphardt, et al.
Leukemia|March 5, 2004
Addition of cladribine to daunorubicin and cytarabine increases complete remission rate after a single course of induction treatment in acute myeloid leukemia. Multicenter, phase III studyJ Holowiecki, S Grosicki, T Robak, et al.
Occupational and Environmental Medicine|October 22, 2010
Considerations of circadian impact for defining 'shift work' in cancer studies: IARC Working Group ReportRichard G Stevens, Johnni Hansen, Giovanni Costa, et al.
Leukemia & Lymphoma|August 1, 1996
Intermittent 2-hour intravenous infusions of 2-chlorodeoxyadenosine in the treatment of 110 patients with refractory or previously untreated B-cell chronic lymphocytic leukemiaT Robak, M Błasinka-Morawiec, E Krykowski, et al.
Acta Haematologica Polonica|July 1, 1981
[Treatment of acute leukemias in adults. IV. Treatment results on 375 patients at 9 hematology centers]D Apel, M Bielawiec, A Bodzenta, et al.
Cell Reports|July 9, 2014
S-nitrosylation-mediated redox transcriptional switch modulates neurogenesis and neuronal cell deathShu-Ichi Okamoto, Tomohiro Nakamura, Piotr Cieplak, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|May 6, 2024
[Early Detection Of Type 1 Diabetes By Islet Autoantibody Screening: A Position Paper Of The Fr1daplex Project Leaders And Training Centres, Bvkj Bavaria And Paednetz (Registered) Bavaria]Peter Achenbach, Reinhard Berner, Ezio Bonifacio, et al.
Pageof 89

Showing results (851-860 of 883) with videos related to

Sort By:
Pageof 89
Breast Cancer Research and Treatment|June 28, 2005
Breast cancer predisposing alleles in PolandB Górski, C Cybulski, T Huzarski, et al.
Journal of Medical Genetics|May 10, 2005
A common variant of CDKN2A (p16) predisposes to breast cancerT Debniak, B Górski, T Huzarski, et al.
Breast Cancer Research and Treatment|October 15, 2013
Preemptive tumor profiling for biomarker-stratified early clinical drug development in metastatic breast cancer patientsAnja Welt, Mitra Tewes, Bahriye Aktas, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 20, 2014
Submesoscale dispersion in the vicinity of the Deepwater Horizon spillAndrew C Poje, Tamay M Ozgökmen, Bruce L Lipphardt, et al.
Leukemia|March 5, 2004
Addition of cladribine to daunorubicin and cytarabine increases complete remission rate after a single course of induction treatment in acute myeloid leukemia. Multicenter, phase III studyJ Holowiecki, S Grosicki, T Robak, et al.
Occupational and Environmental Medicine|October 22, 2010
Considerations of circadian impact for defining 'shift work' in cancer studies: IARC Working Group ReportRichard G Stevens, Johnni Hansen, Giovanni Costa, et al.
Leukemia & Lymphoma|August 1, 1996
Intermittent 2-hour intravenous infusions of 2-chlorodeoxyadenosine in the treatment of 110 patients with refractory or previously untreated B-cell chronic lymphocytic leukemiaT Robak, M Błasinka-Morawiec, E Krykowski, et al.
Acta Haematologica Polonica|July 1, 1981
[Treatment of acute leukemias in adults. IV. Treatment results on 375 patients at 9 hematology centers]D Apel, M Bielawiec, A Bodzenta, et al.
Cell Reports|July 9, 2014
S-nitrosylation-mediated redox transcriptional switch modulates neurogenesis and neuronal cell deathShu-Ichi Okamoto, Tomohiro Nakamura, Piotr Cieplak, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|May 6, 2024
[Early Detection Of Type 1 Diabetes By Islet Autoantibody Screening: A Position Paper Of The Fr1daplex Project Leaders And Training Centres, Bvkj Bavaria And Paednetz (Registered) Bavaria]Peter Achenbach, Reinhard Berner, Ezio Bonifacio, et al.
Pageof 89